LALITA TANTISIRA: Open Payments
NPI 1508874298 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$236 in 12 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $138 · 2025 $236
Food & beverage: $236
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $58 |
| Currax Pharmaceuticals LLC | 3 | $47 |
| Lilly USA, LLC | 2 | $45 |
| EVOKE PHARMA, INC. | 1 | $27 |
| Madrigal Pharmaceuticals | 1 | $23 |
| VIVUS LLC | 1 | $22 |
| Inspire Medical Systems, Inc. | 1 | $14 |
Products named: Wegovy, CONTRAVE, MOUNJARO, GIMOTI, REZDIFFRA, QSYMIA, INSPIRE.
Industry payments across CA — which companies pay providers there.
